NCT06577831

Brief Summary

Pelvic floor disorders affect a large population of women and are responsible for a significant impairment in their quality of life, but the pathophysiology of these disorders is still poorly understood. The project proposes to define new ultra-fast 3D MRI sequences to capture the movements of the main pelvic organs. Visualization of 3D volumes is of great importance to clinicians, but data size hinders clinical use. This study is the first to propose a dynamic 3D representation of pelvic organs, together with quantitative estimates of the deformations undergone. The method is based on four steps: dynamic acquisition, organ segmentation, temporal reconstruction, quantification and visualization of deformations. The D3-Pelvis project responds to the challenge of "technologies for health" with dynamic 3D MRI acquisition and 3D modeling, offering prospects for diagnostic aids and simulators.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 25, 2022

Completed
2.5 years until next milestone

First Submitted

Initial submission to the registry

August 27, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 29, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 24, 2025

Completed
Last Updated

November 20, 2025

Status Verified

November 1, 2025

Enrollment Period

3 years

First QC Date

August 27, 2024

Last Update Submit

November 17, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Develop new three-dimensional analysis tools combining high spatial resolution static MRI with ultra-fast dynamic MRI.

    a metric for displacement of the anchor points of the targeted pelvic organs will be evaluated

    0 month

Study Arms (2)

patient

EXPERIMENTAL

Patients requiring dynamic MRI for the diagnosis of pelvic static disorders

Diagnostic Test: dynamic MRI

control

ACTIVE COMPARATOR

Healthy volunteers for a dynamic MRI

Diagnostic Test: dynamic MRI

Interventions

dynamic MRIDIAGNOSTIC_TEST

* MRI sequences will be performed for patients and healthy volunteers i * Vaginal and rectal tagging will be performed using a water-based ultrasound gel. * The gel will be inserted by an authorized person (nurse or doctor) using a syringe with a conical tip and, optionally, a probe. * MRI sequences. * Data analysis and interpretation.

controlpatient

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult women, +/- of childbearing age, with or without effective contraception.
  • Informed consent signed prior to any procedure described in the study.

You may not qualify if:

  • Contraindication to MRI,
  • Impossibility of performing the examination during thrust,
  • Minor patients
  • Pregnant or breast-feeding women,
  • Women of legal age under guardianship
  • Persons staying in a health or social institution,
  • People in emergency situations,
  • Persons not covered by a social security scheme,
  • Persons deprived of their liberty.
  • Specifically, women with IUDs will be excluded if they cannot remove them before the examination.
  • For healthy volunteers: history of colorectal surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assistance Publique Hopitaux de Marseille _ Hopital de la Timone

Marseille, France, 13005, France

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 27, 2024

First Posted

August 29, 2024

Study Start

February 25, 2022

Primary Completion

February 24, 2025

Study Completion

February 24, 2025

Last Updated

November 20, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations